These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16973608)

  • 1. Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme.
    Havemeyer A; Bittner F; Wollers S; Mendel R; Kunze T; Clement B
    J Biol Chem; 2006 Nov; 281(46):34796-802. PubMed ID: 16973608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).
    Clement B; Mau S; Deters S; Havemeyer A
    Drug Metab Dispos; 2005 Nov; 33(11):1740-7. PubMed ID: 16118330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrochemical and mARC-catalyzed enzymatic reduction of para-substituted benzamidoximes: consequences for the prodrug concept "amidoximes instead of amidines".
    Bauch E; Reichmann D; Mendel RR; Bittner F; Manke AM; Kurz P; Girreser U; Havemeyer A; Clement B
    ChemMedChem; 2015 Feb; 10(2):360-7. PubMed ID: 25512261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of N-hydroxy-sulfonamides, including N-hydroxy-valdecoxib, by the molybdenum-containing enzyme mARC.
    Havemeyer A; Grünewald S; Wahl B; Bittner F; Mendel R; Erdélyi P; Fischer J; Clement B
    Drug Metab Dispos; 2010 Nov; 38(11):1917-21. PubMed ID: 20699408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of the protein components of the liver microsomal O2-insensitive NADH-benzamidoxime reductase.
    Clement B; Lomb R; Möller W
    J Biol Chem; 1997 Aug; 272(31):19615-20. PubMed ID: 9235969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amidoxime reductase system containing cytochrome b5 type B (CYB5B) and MOSC2 is of importance for lipid synthesis in adipocyte mitochondria.
    Neve EP; Nordling A; Andersson TB; Hellman U; Diczfalusy U; Johansson I; Ingelman-Sundberg M
    J Biol Chem; 2012 Feb; 287(9):6307-17. PubMed ID: 22203676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime.
    Andersson S; Hofmann Y; Nordling A; Li XQ; Nivelius S; Andersson TB; Ingelman-Sundberg M; Johansson I
    Drug Metab Dispos; 2005 Apr; 33(4):570-8. PubMed ID: 15640373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs.
    Gruenewald S; Wahl B; Bittner F; Hungeling H; Kanzow S; Kotthaus J; Schwering U; Mendel RR; Clement B
    J Med Chem; 2008 Dec; 51(24):8173-7. PubMed ID: 19053771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice.
    Jakobs HH; Mikula M; Havemeyer A; Strzalkowska A; Borowa-Chmielak M; Dzwonek A; Gajewska M; Hennig EE; Ostrowski J; Clement B
    PLoS One; 2014; 9(8):e105371. PubMed ID: 25144769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells.
    Plitzko B; Ott G; Reichmann D; Henderson CJ; Wolf CR; Mendel R; Bittner F; Clement B; Havemeyer A
    J Biol Chem; 2013 Jul; 288(28):20228-37. PubMed ID: 23703616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of protein variants encoded by nonsynonymous single nucleotide polymorphisms in MARC1 and MARC2 in healthy Caucasians.
    Ott G; Reichmann D; Boerger C; Cascorbi I; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
    Drug Metab Dispos; 2014 Apr; 42(4):718-25. PubMed ID: 24423752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of sulfurated molybdenum cofactor to the C-terminal domain of ABA3 from Arabidopsis thaliana provides insight into the mechanism of molybdenum cofactor sulfuration.
    Wollers S; Heidenreich T; Zarepour M; Zachmann D; Kraft C; Zhao Y; Mendel RR; Bittner F
    J Biol Chem; 2008 Apr; 283(15):9642-50. PubMed ID: 18258600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fourth mammalian molybdenum enzyme mARC: current state of research.
    Havemeyer A; Lang J; Clement B
    Drug Metab Rev; 2011 Nov; 43(4):524-39. PubMed ID: 21942410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase.
    Saulter JY; Kurian JR; Trepanier LA; Tidwell RR; Bridges AS; Boykin DW; Stephens CE; Anbazhagan M; Hall JE
    Drug Metab Dispos; 2005 Dec; 33(12):1886-93. PubMed ID: 16131524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of N-hydroxylated compounds: amidoximes (N-hydroxyamidines) as pro-drugs of amidines.
    Clement B
    Drug Metab Rev; 2002 Aug; 34(3):565-79. PubMed ID: 12214667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of stearoyl-CoA desaturase in the reduction of amidoxime prodrugs.
    Reh R; Ozols J; Clement B
    Xenobiotica; 2008 Sep; 38(9):1177-90. PubMed ID: 18609446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mammalian molybdenum enzymes of mARC.
    Ott G; Havemeyer A; Clement B
    J Biol Inorg Chem; 2015 Mar; 20(2):265-75. PubMed ID: 25425164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molybdenum cofactor enzyme mARC: Moonlighting or promiscuous enzyme?
    Llamas A; Chamizo-Ampudia A; Tejada-Jimenez M; Galvan A; Fernandez E
    Biofactors; 2017 Jul; 43(4):486-494. PubMed ID: 28497908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of amphetamine hydroxylamine and other aliphatic hydroxylamines by benzamidoxime reductase and human liver microsomes.
    Clement B; Behrens D; Möller W; Cashman JR
    Chem Res Toxicol; 2000 Oct; 13(10):1037-45. PubMed ID: 11080052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of in vitro biotransformation of new, orally active, direct thrombin inhibitor ximelagatran, an amidoxime and ester prodrug.
    Clement B; Lopian K
    Drug Metab Dispos; 2003 May; 31(5):645-51. PubMed ID: 12695354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.